Arrowhead Pharmaceuticals, Inc. (ARWR)
56.75
+0.85
(+1.52%)
USD |
NASDAQ |
Oct 19, 13:18
Arrowhead Pharmaceuticals Cash from Operations (Annual) : 179.55M for Sept. 30, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| September 30, 2025 | 179.55M |
| September 30, 2024 | -462.85M |
| September 30, 2023 | -153.89M |
| September 30, 2022 | -136.13M |
| September 30, 2021 | 171.22M |
| September 30, 2020 | -95.39M |
| September 30, 2019 | 173.03M |
| September 30, 2018 | -47.22M |
| September 30, 2017 | -23.94M |
| September 30, 2016 | -64.43M |
| September 30, 2015 | -65.71M |
| September 30, 2014 | -35.42M |
| September 30, 2013 | -19.03M |
| September 30, 2012 | -15.34M |
| Date | Value |
|---|---|
| September 30, 2011 | -7.656M |
| September 30, 2010 | -7.697M |
| September 30, 2009 | -15.28M |
| September 30, 2008 | -27.58M |
| September 30, 2007 | -23.87M |
| September 30, 2006 | -14.79M |
| September 30, 2005 | -9.099M |
| September 30, 2004 | -2.314M |
| September 30, 2003 | -0.1576M |
| September 30, 2002 | -0.1058M |
| September 30, 2001 | -0.0818M |
| September 30, 2000 | -0.0801M |
| September 30, 1999 | -0.0352M |
| September 30, 1998 | -0.0461M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Moderna, Inc. | -1.873B |
| Sarepta Therapeutics, Inc. | -222.54M |
| Revolution Medicines, Inc. | -897.74M |
| Intellia Therapeutics, Inc. | -394.74M |
| Twist Bioscience Corp. | -47.63M |